Are frail elderly people in Europe high-need subjects? First evidence from the SPRINTT data

被引:11
作者
Sicsic, Jonathan [1 ]
Ravesteijn, Bastian [2 ]
Rapp, Thomas [1 ]
机构
[1] Univ Paris, LIRAES, F-75006 Paris, France
[2] Erasmus Sch Econ, Rotterdam, Netherlands
关键词
Frailty; Sarcopenia; Long-term care; Health care use; SPRINTT trial; HEALTH-CARE; OLDER-PEOPLE; HOME-CARE; PHYSICAL FRAILTY; SARC-F; SARCOPENIA; COMMUNITY; DEFINITION; PREVALENCE; DISABILITY;
D O I
10.1016/j.healthpol.2020.05.009
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Physical frailty and sarcopenia (PF&S) has received growing attention in empirical models of health care use. However, few articles focused on objective measures of PF&S to assess the extent of care consumption among the frail population at risk of dependency. Using baseline data from the SPRINTT study, a sample of 1518 elderly people aged 70+ recruited in eleven European countries, we analyse the association between various PF&S measures and health care/long term care (LTC) use. Multiple health care and LTC outcomes are modelled using linear probability models adjusted for a range of individual characteristics and country fixed effects. We find that PF&S is associated with a significant increase in emergency admissions and hospitalizations, especially among low-income elders. All PF&S measures are significantly associated with increased use of formal and informal LTC. There is a moderating effect of income on LTC use: poor frail elders are more likely to use any of the formal LTC services than rich frail elders. Our results are robust to various statistical specifications. They suggest that the inclusion of PF&S in the eligibility criteria of public LTC allowances could contribute to decrease the economic gradient in care use among the elderly community-dwelling European population. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页码:865 / 872
页数:8
相关论文
共 54 条
  • [1] Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1
  • [2] [Anonymous], 2016, BMC GERIATRICS, DOI DOI 10.1186/S12877-016-0309-Z
  • [3] [Anonymous], 2014, PLOS ONE
  • [4] [Anonymous], 2017, HLTH GLANCE 2017 OEC, DOI DOI 10.1787/HEALTH_GLANCE-2017-EN
  • [5] Estimation of sarcopenia prevalence using various assessment tools
    Beaudart, C.
    Reginster, J. Y.
    Slomian, J.
    Buckinx, F.
    Dardenne, N.
    Quabron, A.
    Slangen, C.
    Gillain, S.
    Petermans, J.
    Bruyere, O.
    [J]. EXPERIMENTAL GERONTOLOGY, 2015, 61 : 31 - 37
  • [6] Bentur N, 2016, ISR MED ASSOC J, V18, P449
  • [7] Associations of frailty with health care costs - results of the ESTHER cohort study
    Bock, Jens-Oliver
    Koenig, Hans-Helmut
    Brenner, Hermann
    Haefeli, Walter E.
    Quinzler, Renate
    Matschinger, Herbert
    Saum, Kai-Uwe
    Schoettker, Ben
    Heider, Dirk
    [J]. BMC HEALTH SERVICES RESEARCH, 2016, 16
  • [8] Brugiavini A, 2017, VULNERABILITY LONG T, P25, DOI [10.1007/978-3-319-68969-23, DOI 10.1007/978-3-319-68969-23]
  • [9] Frailty prevalence and slow walking speed in persons age 65 and older: implications for primary care
    Castell, Maria-Victoria
    Sanchez, Mercedes
    Julian, Rosa
    Queipo, Rocio
    Martin, Sagrario
    Otero, Angel
    [J]. BMC FAMILY PRACTICE, 2013, 14
  • [10] Cawthon PM, 2014, J GERONTOL A-BIOL, V69, P567, DOI 10.1093/gerona/glu023